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3. Results and discussion
Table 1. Content of peptides RYLGY and AYFYPEL (mg/g of dried product) in the casein 
hydrolysate prepared on a laboratory scale. The ACE-inhibitory activity was expressed as IC50
value (μg of dried product/mL). 
3.1. Effect of drying 
3.2. Effect of pasteurization and homogenization.  Stability during 
shelf-life
The antihypertensive activity of the casein 
hydrolysate ingredients, with or without the 
additive, obtained on a large scale was 
maintained after atomization (Fig. 2).
Fig. 2. Antihypertensive activity in SHR after oral 
administration of different powdered ingredients.
Fig. 3. (A) Effects of pasteurization and homogenization on the concentration (μg/mL of WSE) of peptides 
RYLGY (   ) and AYFYPEL (   ) and their stability in yoghurts at refrigerated storage. (B) The ACE inhibitory 
activity was expressed as IC50 value (μL of WSE).  
IC50 = 99.11 μg of dried product/mL
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STABILITY TO TECHNOLOGICAL PROCESSES 
OF ANTIHYPERTENSIVE PEPTIDES
? In a previous study, two novel antihypertensive peptides, which corresponded to fragments f(90-
94) (RYLGY) and f(143-149) (AYFYPEL) of αs1-CN, have been identified in a peptic bovine casein 
hydrolysate (Contreras et al., 2009).
? A relevant question for the industrial application of bioactive peptides is if these compounds would 
survive to processing conditions. However, there are little data about this issue. 
1. Introduction
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The active peptides were stable during the processes of homogenization and pasteurization. 
Moreover, no significant reduction of both peptides was detected during the shelf-life of the 
yoghurts prepared on pilot (Fig. 3) and large scale (data not shown). 
RYLGY = 0.79 mg/g and AYFYPEL = 2.17 mg/g
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In addition, the peptides were quantified by HPLC-MS, using 
the method of Contreras et al. (2010). Anal Bioanal Chem 397, 
2825-2832. The ACE-inhibitory activity was determined as 
previously described Quirós et al. (2009). Peptides 30, 1848–
1853, and the antihypertensive activity was evaluated 
accordingly to Contreras et al. (2009). Int Dairy J 19, 566-573. 
Preparation of the casein hydrolysate
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The moment of the incorporation of a food additive did not affect the peptide content in the final 
ingredient (Table 1). In addition, the content of both peptides and the ACE-inhibitory activity were 
comparable after spray-drying and freeze-drying and between both scales, with (Table 1) or without 
(data not shown) the incorporation of the additive during the processing of the hydrolysate.
Treatment 2
Yoghurts prepared on a large scale
The main objective was to evaluate the resistance of the peptides RYLGY and AYFYPEL to drying, homogenization and pasteurization, and 
their stability in yoghurts stored at 4 ºC. The stability of the ACE-inhibitory activity and the antihypertensive activity was also evaluated.
